Graft-versus-host disease after donor leukocyte infusions: presentation and management.
about
Adoptive T-cell therapy for LeukemiaRecipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsCostimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantationAllogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseHigh-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.Genetic modification of human T lymphocytes for the treatment of hematologic malignancies.Cellular therapy following allogeneic stem-cell transplantation.Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyClinical management of patients receiving cell-based immunoregulatory therapy.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Chimeric antigen receptor T-cell therapies for lymphoma.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases.In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host disease.CD4+ T cell-depleted lymphocyte infusion impairs neither the recovery of recipient thymus nor the development of transplanted thymus.Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent.Posttransplant chimeric antigen receptor therapy.Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
P2860
Q27006934-DFB71712-9F16-4977-85C0-52CEE27C1FCDQ34612631-AB41F838-9C7D-48CC-9ABB-F12CC1669184Q35743874-9C48B529-10BB-4CE7-ACC4-B841B2D00BD8Q35891651-A7988F22-0F2D-4CCF-B97F-4BAC2D4EDD34Q35904666-F0C6B4A1-BE33-40CF-98FF-62A1EBB02548Q36117735-BBABCEDB-642B-4331-B64D-5F83BF87B8CAQ36366557-E8D2AA68-6446-4309-A68E-02E6C858E80BQ36612643-3D9C3618-A82E-4B35-8DBA-70AEAEC2BF41Q37263151-B4C73B18-2155-4C8C-8F1C-D1A262801D5AQ38201742-1048548B-1C32-428F-8EB9-1AC2571A5BBDQ38417056-D9EA8A97-AD08-4955-B6BB-D1360E1821A7Q38600697-D95D79D2-1CA2-45BA-B146-C58A70D6F05AQ38643400-3AE38D04-82B6-4840-8B09-52E3A11A7C91Q39115858-F5335C70-9589-4E2B-BDCD-093D6E8627CEQ40533264-DC5A1F3B-1A77-4226-A968-1856FC46E79EQ41577884-028EC9D3-BF83-4F6B-AD51-A6A9FB652AE5Q42117471-365AC3AB-5EED-4163-92BC-9DB307A8F78BQ44208467-8EC94C11-8AF8-479D-B9F7-839ED6EF7E67Q45077774-44309B7E-C06B-495F-BFF0-15306CB5C719Q47550219-53446EEF-F098-4529-99FF-AF9F8BAE91D7Q48105490-6D030472-EEA8-4205-973A-CC920F4DABD5Q48306919-E6F1D4D1-8F1D-4D22-A5E7-42B76B462BCDQ57177485-2718FEF4-ACAC-476D-8B63-D70CECA29AC2
P2860
Graft-versus-host disease after donor leukocyte infusions: presentation and management.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Graft-versus-host disease after donor leukocyte infusions: presentation and management.
@en
type
label
Graft-versus-host disease after donor leukocyte infusions: presentation and management.
@en
prefLabel
Graft-versus-host disease after donor leukocyte infusions: presentation and management.
@en
P2860
P1476
Graft-versus-host disease after donor leukocyte infusions: presentation and management.
@en
P2093
David L Porter
Noelle V Frey
P2860
P304
P356
10.1016/J.BEHA.2008.02.007
P577
2008-06-01T00:00:00Z